Primary combined-modality therapy for esophageal cancer

ONCOLOGY

Volumn 20, Issue 5, 2006, Pages 497-505

  Minsky, Bruce D ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PACLITAXEL; TRASTUZUMAB; ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; BRACHYTHERAPY; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DYSPHAGIA; ESOPHAGITIS; ESOPHAGUS CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FRACTIONATION; HUMAN; INTERMETHOD COMPARISON; LETHARGY; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TRACHEOESOPHAGEAL FISTULA; TREATMENT FAILURE; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ALGORITHM; ESOPHAGUS TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL;

ALGORITHMS; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33750124841     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Pohl H, Welch HG: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142-146, 2005.
2. De-Ren S: Ten-year follow-up of esophageal cancer treated by radical radiation therapy: Analysis of 869 patients. Int J Radiat Oncol Biol Phys 16:329-334, 1989.
3. Newaishy GA, Read GA, Duncan W, et al: Results of radical radiotherapy of squamous cell carcinoma of the esophagus. Clin Radiol 33:347-352, 1982.
4. Okawa T, Kita M, Tanaka M, et al: Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 17:49-54, 1989.
5. Herskovic A, Martz LK, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992.
6. Al-Sarraf M, Martz K, Herskovic A, et al: Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients with esophageal cancer. Final report of an Intergroup randomized and confirmed study (abstract 464). Proc Am Soc Clin Oncol 15:206, 1996.
7. Sykes AJ, Burt PA, Slevin NJ, et al: Radical radiotherapy for carcinoma of the oesophagus: An effective alternative to surgery. Radiother Oncol 48:15-21, 1998.
8. Sai H, Mitsumori M, Arai K, et al: Long-term results of definitive radiotherapy for stage I esophageal cancer. Int J Radiat Oncol Biol Phys 62:1339-1344, 2005.
9. Al-Sarraf M, Martz K, Herskovic A, et al: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 15:277-284, 1997.
10. Cooper JS, Guo MD, Herskovic A, et al: Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 281:1623-1627, 1999.
11. Streeter OE, Martz KL, Gaspar LE, et al: Does race influence survival for esophageal cancer patients treated on the radiation and chemotherapy arm of RTOG # 85-01? Int J Radiat Oncol Biol Phys 44:1047-1052, 1999.
12. Suntharalingam M, Moughhan J, Coia LR, et al: Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus. J Clin Oncol 23:2325-2331, 2005.
13. Kenjo M, Oguchi M, Gomi K, et al: Radiation therapy for esophageal cancer: Results of the patterns of care study in Japan 1995-1997. Esophagus 2:77-83, 2005.
14. Bains MS, Stojadinovic A, Minsky B, et al: A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: Initial results. J Thorac Cardiovasc Surg 124:270-277, 2002.
15. Goldberg M, Lampert C, Colarusso P, et al: Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: A phase I report (abstract 612). Proc Am Soc Clin Oncol 21:154a, 2002.
16. Ilson DH, Bains M, Kelsen DP, et al: Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. J Clin Oncol 21:2926-2932, 2003.
17. Ott K, Fink U, Becker K, et al: Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial. J Clin Oncol 21:4604-4610, 2003.
18. Wieder HA, Brucher BL, Zimmermann F, et al: Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22:900-908, 2004.
19. Kelsen DP, Ginsberg R, Pajak T, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984, 1998.
20. Armstrong JG: High dose rate remote afterloading brachytherapy for lung and esophageal cancer. Semin Radiat Oncol 4:270-277, 1993.
21. Homs MY, Essink-Bot ML, Borsboom GJJM, et al: Quality of life after palliative treatment for oesophageal carcinoma - a prospective comparison between stent placement and single dose chemotherapy. Eur J Cancer 40:1862-1871, 2004.
22. Okawa T, Dokiya T, Nishio M, et al: Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Int J Radiat Oncol Biol Phys 45:623-628, 1999.
23. Calais G, Dorval E, Louisot P, et al: Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: Results of a pilot study. Int J Radiat Oncol Biol Phys 38:769-775, 1997.
24. Yorozu A, Dokiya T, Oki Y, et al: Curative radiotherapy with high-dose-rate brachytherapy boost for localized esophageal carcinoma: Dose-effect relationship of brachytherapy with the balloon type applicator system. Radiother Oncol 51:133-139, 1999.
25. Gaspar LE, Qian C, Kocha WI, et al: A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): Preliminary toxicity report. Int J Radiat Oncol Biol Phys 37:593-599, 1997.
26. Gaspar LE, Nag S, Herskovic A, et al: American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Int J Radiat Oncol Biol Phys 38:127-132, 1997.
27. Zhang Z, Liao Z, Jin J, et al: Dose response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61:656-664, 2005.
28. Calais G, Jadaud E, Chapet S, et al: High dose radiotherapy (RT) and concomitant chemotherapy for nonresectable esophageal cancer. Results of a phase II study (abstract). Proc Am Soc Clin Oncol 13:197, 1994.
29. Minsky BD, Neuberg D, Kelsen DP, et al: Final report of intergroup trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43:517-523, 1999.
30. Minsky BD, Pajak T, Ginsberg RJ, et al: INT 0123 (RTOG 94-05) phase III trial of combined-modality therapy for esophageal cancer: High dose (64.8 Gy) vs. standard dose (50.4 Gy) radiation therapy. J Clin Oncol 20:1167-1174, 2002.
31. Wang Y, Shi XH, He SQ, et al: Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 54:131-136, 2002.
32. Zhao KL, Shi XH, Jiang GL, et al: Late course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma. Int J Radiat Oncol Biol Phys 60:123-129, 2004.
33. Choi N, Park SD, Lynch T, et al: Twice-daily radiotherapy as concurrent boost technique during chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: Mature results of a phase II study. Int J Radiat Oncol Biol Phys 60:111-122, 2004.
34. Jacob JH, Seitz JF, Langlois C, et al: Definitive concurrent chemo-radiation therapy (CRT) in squamous cell carcinoma of the esophagus (SCCE): Preliminary results of a French randomized trial comparing standard vs. split course irradiation (FNCLCC-FFCD 9305) (abstract 1035). Proc Am Soc Clin Oncol 18:270a, 1999.
35. Sugahara S, Tokuuye K, Okumura T, et al: Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys 61:76-84, 2005.
36. Nutting CM, Bedford JL, Cosgrove VP, et al: A comparison of conformal and intensity-modulated techniques for esophageal radiotherapy. Radiother Oncol 61:157-163, 2001.
37. Phillips TL, Minsky BD, Dicker AP: Cancer of the esophagus, in Leibel SA, Phillips TL (eds): Textbook of Radiation Oncology, 1st ed, pp 601-623. Philadelphia, W.B. Saunders, 1998.
38. Tai P, van Dyk J, Yu E, et al: Variability of target volume delineation in cervical esophageal cancer. Int J Radiat Oncol Biol Phys 42:277-288, 1998.
39. Konski A, Doss M, Milestone B, et al: The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61:1123-1128, 2005.
40. Larson SM, Schoder H, Yeung H: Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer. Cancer J 10:243-250, 2004.
41. van Westreenen HL, Heeren PAM, Jager PL, et al: Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography. Ann Surg Oncol 10:1105, 2003.
42. Flamen P, van Cutsem E, Lerut T, et al: Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced esophageal cancer. Ann Oncol 13:361-368, 2002.
43. Downey RJ, Akhurst T, Ilson D, et al: Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: Results of a prospective trial. J Clin Oncol 21:428-432, 2003.
44. Tai P, Van Dyk J, Battista J, et al: Improving the consistency in cervical esophageal target volume definition by special training. Int J Radiat Oncol Biol Phys 53:766-774, 2002.
45. Nutting CM, Bedford JL, Cosgrove VP, et al: A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. Radiother Oncol 61:157-163, 2001.
46. Font A, Garcia-Alfonso P, Arellano A, et al: Preoperative combined multimodal therapy with docetaxel plus 5-fluorouracil and concurrent hyperfractionated radiotherapy for locally advanced esophageal cancer (abstract 2326). Proc Am Soc Clin Oncol 21:128b, 2002.
47. Ilson DH, Minsky B, Kelsen D: Irinotecan cisplatin and radiation in esophageal cancer. Oncology (Williston Park) 16(suppl 5):11-15, 2002.
48. D'Adamo DR, Bains M, Minsky B, et al: A phase I trial of paclitaxel, cisplatin, irinotecan, and concurrent radiation therapy in locally advanced esophageal cancer (abstract 1401). Proc Am Soc Clin Oncol 22:349, 2003.
49. Safran H, DiPetrillo T, Nadeem A, et al: Neoadjuvant herceptin, paclitaxel, cisplatin, and radiation for adenocarcinoma of esophagus: A phase I study (abstract 560). Proc Am Soc Clin Oncol 21:141a, 2002.
50. Khushalani KI, Leichman CG, Proulx G, et al: Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: Report of a clinical trial for patients with esophageal cancer. J Clin Oncol 20:2844-2850, 2002.
51. Chiarion-Sileni V, Corti L, Innocente R, et al: Oxaliplatin (OX) and leucovorin (L) combined with protracted- infusion fluorouracil (F) and radiation (XRT) in locally advanced esophageal cancer (LAEC): A multicentric phase D study (abstract 4071). J Clin Oncol 23(16S):325s, 2005.
52. Berger AC, Farma J, Scott WJ, et al: Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23:4330-4337, 2005.
53. Sarbia M, Stahl M, Fink U, et al: Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities. Clin Cancer Res 4:2991-2997, 1998.
54. Pomp J, Davelaar J, Blom J, et al: Radiotherapy for oesophagus carcinoma: The impact of p53 on treatment outcome. Radiother Oncol 46:179-184, 1998.
55. Merchant TE, Minsky BD, Lauwers GY, et al: Esophageal cancer phospholipids correlated with histopathologic findings: A 31P NMR study. NMR Biomed 12:184-188, 1999.
56. Kishi K, Doki Y, Miyata H, et al: Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer (abstract). Br J Surg 89:597-603, 2002.
57. Hironaka S, Hasebe T, Kamijo T, et al: Biopsy specimen microvessel density is a useful prognostic marker in patients with T2-4M0 esophageal cancer treated with chemoradiotherapy. Clin Cancer Res 8:124-130, 2002.
58. Nomiya T, Nemoto K, Miyachi H, et al: Relationships between radiosensitivity and microvascular density in esophageal carcinoma: Significance of hypoxic fraction. Int J Radiat Oncol Biol Phys 58:589-596, 2005.
59. Morita M, Kuwano H, Araki K, et al: Prognostic significance of lymphocytic infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer. Int J Radiat Oncol Biol Phys 49:1259-1266, 2001.
60. Akamatsu M, Matsumoto T, Oka K, et al: c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 57:1323-1327, 2003.
61. Kalha I, Kaw M, Fukami N, et al: The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy. Cancer 101:940-947, 2004.
62. Lim JT, Truong PT, Berthelet E, et al: Endoscopic response predicts for survival and organ preservation after primary chemoradiation for esophageal cancer. Int J Radiat Oncol Biol Phys 57:1328-1335, 2003.
63. Brink I, Hentschel M, Bley TA, et al: Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma. Eur J Surg Oncol 30:544-550, 2004.
64. Brucher BL, Stein HJ, Zimmermann F, et al: Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: Results of a prospective phase-II trial. Eur J Surg Oncol 30:963-971, 2004.
65. Bedenne L, Michel P, Bouche O, et al: Randomized phase III trial in locally advanced esophageal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102) (abstract 519). Proc Am Soc Clin Oncol 21:130a, 2002.
66. Bonnetain F, Bedenne L, Michel P, et al: Definitive results of a comparative longitudinal quality of life study using the Spitzer index in the randomized multicentric phase III trial FFCD 9102 (surgery vs. radiochemotherapy in patients with locally advanced esophageal cancer) (abstract 1002). Proc Am Soc Clin Oncol 22:250, 2003.
67. Stahl M, Stuschke M, Lehmann N, et al: Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310-2317, 2005.
68. Coia LR, Soffen EM, Schultheiss TE, et al: Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. Cancer 71:281-286, 1993.
69. Sur RK, Singh DP, Sharma SC: Radiation therapy of esophageal cancer: Role of high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 22:1043-1046, 1992.
70. Sur RK, Donde B, Levin VC, et al: Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys 40:447-453, 1998.
71. Gergel TJ, Leichman LL, Nava HR, et al: Effect of concurrent radiation therapy and chemotherapy on pulmonary function in patients with esophageal cancer: Dose-volume histogram analysis. Cancer J 8:451-460, 2002.
72. Lee HK, Vaporciyan A, Cox JD, et al: Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: Correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57:1317-1322, 2003.
73. Gschossmann JM, Bonner JA, Foote RL, et al: Malignant tracheoesophageal fistula in patients with esophageal cancer. Cancer 72:1513-1521, 1993.